Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
2-(3-chloro-4-propoxyphenyl)acetic acid is a small molecule belonging to the phenol ether and phenylacetic acid derivative classes. It features a phenyl ring substituted with both chloro and propoxy groups and an acetic acid side chain. This compound has been investigated as a drug candidate primarily for its potential biological activities such as anti-inflammatory and analgesic effects. Its mechanism of action involves inhibition of prostaglandin G/H synthase 1 (PTGS1), also known as cyclooxygenase 1 (COX1), which is key in the biosynthesis of prostaglandins from arachidonic acid—a pathway central to inflammation and pain signaling[1][5][8]. The compound has mainly been used in research settings as a discovery agent or probe rather than an approved pharmaceutical.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 2-(3-chloro-4-propoxyphenyl)acetic acid.